Sign in

CIK 0001231457 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

GENELUX Corp

Sign in to watch
Ticker
GNLX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
805-267-9889
Business address
2625 TOWNSGATE ROAD, SUITE 230, WESTLAKE VILLAGE, CA, 91361
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$155,693
in 6 filings

Net −$155,693. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 71 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-12-30 Tyree James L Director Sale −3,460 $2.46 $9K 45,791
2024-12-18 Smalling Ralph Head of Regulatory Grant or award +15,525 31,847
2024-12-18 Smalling Ralph Head of Regulatory Grant or award · Stock Option (right to buy) +21,100 21,100
2024-12-18 Ryder Sean General Counsel Grant or award +22,000 41,388
2024-12-18 Ryder Sean General Counsel Grant or award · Stock Option (right to buy) +30,000 30,000
2024-12-18 Yu Yong VP, Clinical Trial Operations Grant or award +29,000 39,869
2024-12-18 Yu Yong VP, Clinical Trial Operations Grant or award · Stock Option (right to buy) +39,000 39,000
2024-12-18 Cappello Joseph VP, Pharmaceutical Development Grant or award +29,000 43,653
2024-12-18 Cappello Joseph VP, Pharmaceutical Development Grant or award · Stock Option (right to buy) +39,000 39,000
2024-12-18 Zak Lourie S. Chief Financial Officer Grant or award +41,650 82,452
2024-12-18 Zak Lourie S. Chief Financial Officer Grant or award · Stock Option (right to buy) +56,525 56,525
2024-12-18 Zindrick Thomas President and CEO Grant or award +134,500 171,872
2024-12-18 Zindrick Thomas President and CEO Grant or award · Stock Option (right to buy) +183,000 183,000
2024-12-16 Zindrick Thomas President and CEO Sale −14,315 $2.34 $33K 37,372
2024-12-16 Zak Lourie S. Chief Financial Officer Sale −2,103 $2.34 $5K 40,802
2024-12-16 Smalling Ralph Head of Regulatory Sale −2,510 $2.34 $6K 16,322
2024-12-16 Cappello Joseph VP, Pharmaceutical Development Sale −6,300 $2.34 $15K 14,653
2024-10-18 Scigalla Paul Chief Medical Officer Grant or award · Stock Option (right to buy) +16,666 16,666
2024-10-18 Scigalla Paul Chief Medical Officer Grant or award · Stock Option (right to buy) +16,666 16,666
2024-09-13 Szalay Aladar 10% owner Sale −33,080 $2.57 $85K 599,821

Page 6 of 9 · 170 trades